In prostate cancer patients, Szmulewitz et al. (18) found that high-grade cancers were nearly twice as likely to have relatively low SGK1 staining compared to low-grade cancers (13.8% vs. 26.5%, P = 0.08). The gene discussed is SGK1; the disease is prostate carcinoma.